Evidence map›Paper›PMID 39767808›Full record

ArticleBiomedicines2024

Obinutuzumab in Combination with Alternative Chlorambucil Schedules in Front-Line Treatment of Chronic Lymphocytic Leukemia: A Study by KroHem, the Croatian Cooperative Group for Hematologic Diseases.

Igor Aurer, Ozren Jakšić, Sandra Bašić-Kinda, Karla Mišura-Jakobac, Jasminka Sinčić-Petričević, Sabina Novaković-Coha, Davor Galušić, Hrvoje Holik, Toni Valković, Dubravka Županić-Krmek and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Igor AurerDivision of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb and Medical School, University of Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0001-6175-4277
Ozren JakšićDivision of Hematology, Department of Internal Medicine, University Hospital Dubrava and Medical School, University of Zagreb, 10000 Zagreb, Croatia.
Sandra Bašić-KindaDivision of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
Karla Mišura-JakobacDivision of Hematology, Department of Internal Medicine, University Hospital Merkur, 10000 Zagreb, Croatia.ORCID 0000-0001-7353-8811
Jasminka Sinčić-PetričevićDivision of Hematology, Department of Internal Medicine, University Hospital Centre Osijek, 31000 Osijek, Croatia.
Sabina Novaković-CohaDivision of Hematology, Department of Internal Medicine, University Hospital Centre Sisters of Mercy, 10000 Zagreb, Croatia.
Davor GalušićDivision of Hematology, Department of Internal Medicine, Division of Haematology, University Hospital Centre Split, 21000 Split, Croatia.ORCID 0000-0001-5485-8529
Hrvoje HolikHematology-Oncology Unit, Internal Medicine Service, General Hospital Dr. Josip Benčević, 35000 Slavonski Brod, Croatia.
Toni ValkovićDivision of Hematology, Department of Internal Medicine, University Hospital Centre Rijeka and Medical School, University of Rijeka, 51000 Rijeka, Croatia.
Dubravka Županić-KrmekDivision of Hematology, Department of Internal Medicine, University Hospital Holy Spirit, 10000 Zagreb, Croatia.
Ida Hude-DragičevićDivision of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0001-5527-0647
Vibor MilunovićDivision of Hematology, Department of Internal Medicine, University Hospital Merkur, 10000 Zagreb, Croatia.ORCID 0000-0003-0069-6688
Vlatko PejšaDivision of Hematology, Department of Internal Medicine, University Hospital Dubrava and Medical School, University of Zagreb, 10000 Zagreb, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chlorambucilchronic lymphocytic leukemiaobinutuzumab

Identifiers

PMID39767808
PMCPMC11727279

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.